In the continuing evolution of personalized medicine, a new study has found evidence to support the value of a tool that measures the presence of cancer-derived molecules in the blood of patients with ...

In experiments conducted at the University of São Paulo, tumor stem cells became less able to proliferate and invade tissues ...

A new type of antibody which stimulates the immune system to target cancer cells slows tumour growth, according to new research.

There are three main types of ovarian cancer: epithelial, germ cell, and stromal. Learn about each type’s defining ...

While both are called medullary carcinoma, these cancers differ in many ways: ...

Discover the four vital indicators that your cancer treatment is effective, from tumor shrinkage to symptom relief, helping ...

Dr. Park shares the three biggest takeaways, in his opinion, to have come out of the ASCO GU Symposium, highlighting studies ...

Expert Rev Mol Diagn. 2008;8(5):579-585. Quite a few tumor markers (CEA, CA 19-9, AFP, SCC, CA 72-4.) have already been established in diagnosis and/or surveillance of malignant diseases of the GI ...

The new blood-based assay PAC-MANN-1 (protease activity–based cancer marker using magnetic nanosensor-1) identified pancreatic ductal adenocarcinoma (PDAC) across all stages with high ...

The new research examined whether the MPS2 test could detect cancer markers without this examination. Using urine samples from 266 men who did not undergo a rectal exam, researchers found the test ...

Phase II Study of Ipilimumab, Nivolumab, and Panitumumab in Patients With KRAS/NRAS/BRAF Wild-Type Microsatellite Stable Metastatic Colorectal Cancer Neoadjuvant chemotherapy (NAC) is increasingly ...

A new blood test may help detect pancreatic cancer in its early stages with up to 97% accuracy, according to a recent study. This test looks for specific genetic markers released by pancreatic ...